Skip to main content
Caplight Logo









BioWraptor

BioWraptor

Private
New York City, New YorkHealthcare & Life Scienceshttps://biowraptor.com

Last Round

Pre Seed

Nov 12, 2026

Total Funding Raised

$1.5M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

BioWraptor operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Pre Seed round in November 2026.

BioWraptor is a biotechnology company that develops peptide-based encapsulation methods to maintain the stability of biomolecules at room temperature.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BioWraptor Comparables

Compare BioWraptor with similar companies based on industry and business-model similarity.

BioWraptor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EnsiliTech
86%
Inaedis Inc.
86%
Stablepharma
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

BioWraptor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedNov 12, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

BioWraptor Investors

Notable investors and investment history

BioWraptor investors
InvestorRounds
SNØCAPPre Seed
New York VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2026

    $1.5M raised from SNØCAP and other investors.

Book a demo to see all signals

For institutional investors. Book with your work email.

BioWraptor Filings

Explore SEC and related filing metadata, where available.

BioWraptor filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BioWraptor's valuation, stock price, and market status.

Is BioWraptor a public or private company?

BioWraptor is a private company.

What is the current stock price of BioWraptor?

BioWraptor is a private company, so its shares have no public market price. Caplight tracks BioWraptor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BioWraptor worth (valuation)?

Valuation information for BioWraptor is not publicly available.

Can I buy BioWraptor stock?

BioWraptor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BioWraptor's last funding round?

BioWraptor's most recent funding round was Pre Seed on November 12, 2026.

Who are the main investors in BioWraptor?

Key investors in BioWraptor include SNØCAP, New York Ventures.

Will BioWraptor IPO soon?

No public IPO plans have been announced for BioWraptor.

How can I track BioWraptor secondary market activity?

Caplight tracks bids, offers, and trades in BioWraptor's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range4
Year Founded2024
Last FundingNov 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?